Multiple Myeloma Initial Treatment – What...
Multiple Myeloma
Multiple Myeloma Initial Treatment – What’s Right For You
There is a standard of care for treatment for an initial multiple myeloma diagnosis. Usually, patients are prescribed a combination of three drugs: Bortezomib, Lenalidomide, and Dexamethasone. It’s also possible physicians will consider Cyclophosphimide. There is also evidence that an alternative to Bortezomib is Carfilzomibe.
Doctors will also make decisions about what drugs to prescribe based on any conditions you might have. Maybe you have neuropathy, a condition of numbness and tingling in arms and legs. In this case, Bortezamib would not be a good choice since it can induce neuropathy. Dr. Nina Shah, multiple myeloma specialist from UCSF says your doctor might opt instead to give you the drug called Carfilzomibe. Dr. Shah cites another example. “Let’s say, for example, your kidneys don’t work that well. Maybe in that case, it’ll be hard to get a higher dose of the drug Lenalidomide.” This is a problem because Lenalidomide has been associated with kidney disease.
There may also be patients that doctors don’t think can handle three drugs. In those cases Dr. Shah says they need to consider”the performance status”, meaning how active is the patient? How tough would it be to get three drugs at once?… In that case, it is possible for people to get maybe two drugs at a time.”Man
Your doctor will talk to you about any symptoms and conditions you have, to help make the best decision for you about your treatment.
Learn more about SurvivorNet's rigorous medical review process.
There is a standard of care for treatment for an initial multiple myeloma diagnosis. Usually, patients are prescribed a combination of three drugs: Bortezomib, Lenalidomide, and Dexamethasone. It’s also possible physicians will consider Cyclophosphimide. There is also evidence that an alternative to Bortezomib is Carfilzomibe.
Doctors will also make decisions about what drugs to prescribe based on any conditions you might have. Maybe you have neuropathy, a condition of numbness and tingling in arms and legs. In this case, Bortezamib would not be a good choice since it can induce neuropathy. Dr. Nina Shah, multiple myeloma specialist from UCSF says your doctor might opt instead to give you the drug called Carfilzomibe. Dr. Shah cites another example. “Let’s say, for example, your kidneys don’t work that well. Maybe in that case, it’ll be hard to get a higher dose of the drug Lenalidomide.” This is a problem because Lenalidomide has been associated with kidney disease.
There may also be patients that doctors don’t think can handle three drugs. In those cases Dr. Shah says they need to consider”the performance status”, meaning how active is the patient? How tough would it be to get three drugs at once?… In that case, it is possible for people to get maybe two drugs at a time.”Man
Your doctor will talk to you about any symptoms and conditions you have, to help make the best decision for you about your treatment.
Learn more about SurvivorNet's rigorous medical review process.
Initial Treatment: Deciding How and When to Treat
Initial Treatment: Induction Therapy
Stem cell transplant, also known as bone marrow transplant, is often recommended as a second step in treating multiple myeloma. It’s a major undertaking and not always a straightforward decision.
Initial Treatment: Stem Cell Transplant
Stem cell transplant, also known as bone marrow transplant, is often recommended as a second step in treating multiple myeloma. It’s a major undertaking and not always a straightforward decision.